Ani Pharmaceuticals (ANIP) Cash from Operations Growth (5y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 91.93 Bn | 90.07 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.31 Bn | 32.57 Bn | 1.97 Bn |
| 3 | Zoetis | 33.01 Bn | 31.07 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.96 Bn | 20.81 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.50 Bn | 18.69 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.16 Bn | 16.85 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.84 Bn | 12.41 Bn | 785.00 Mn |
| 10 | Ani Pharmaceuticals | 1.67 Bn | 1.36 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.08% |
| Dec 31, 2025 | 48.90% |
| Sep 30, 2025 | 96.50% |
| Jun 30, 2025 | 29.42% |
| Mar 31, 2025 | 82.89% |
| Dec 31, 2024 | 26.99% |
| Sep 30, 2024 | -10.56% |
| Jun 30, 2024 | 29.70% |
| Mar 31, 2024 | 5.03% |
| Dec 31, 2023 | 10.44% |
| Sep 30, 2023 | 31.06% |
| Jun 30, 2023 | 19.14% |
| Mar 31, 2023 | -1.35% |
| Dec 31, 2022 | -17.90% |
| Sep 30, 2022 | -26.67% |
| Jun 30, 2022 | -548.68% |
| Mar 31, 2022 | -37.42% |
| Dec 31, 2021 | -24.64% |
| Sep 30, 2021 | -47.51% |
| Jun 30, 2021 | -40.88% |